Coronary artery bypass performed without the use of cardiopulmonary bypassis associated with reduced cerebral microemboli and improved clinical results
Bj. Bowles et al., Coronary artery bypass performed without the use of cardiopulmonary bypassis associated with reduced cerebral microemboli and improved clinical results, CHEST, 119(1), 2001, pp. 25-30
Citations number
27
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Study objectives: Strokes and neurocognitive dysfunction have been correlat
ed with cerebral microemboli produced during cardiopulmonary bypass (CPB),
The purpose of this study was to determine whether, and to what extent, off
-pump coronary artery bypass (OPCAB) reduces the occurrence of cerebral mic
roemboli compared with traditional coronary artery bypass grafting (CABG) w
ith CPB and to compare clinical results.
Design and patients: A retrospective review of 137 patients undergoing elec
tive CABG was performed, 70 of whom underwent traditional CABG and 67 of wh
om underwent OPCAB. Using transcranial Doppler ultrasonography, 40 patients
(20 CABG, 20 OPCAB) were continuously monitored intraoperatively for the o
ccurrence and pattern of cerebral microemboli.
Setting: Private, university-affiliated tertiary care hospitals.
Results: There was no statistical difference in the age, sex, or underlying
comorbidities between those patients undergoing CABG and OPCAB, CABG patie
nts did have a slightly lower preoperative ejection fraction (50.9% vs 55.5
%, p = 0.03). Despite these similar preoperative characteristics, the OPCAB
group experienced significant reductions in cerebral microemboli (27 vs 1,
766, p = 0.003), transfusion requirements (29.9% vs 47.1%, p = 0.04), intub
ation time (3.3 vs 9.5 h, p < 0.001), ICU length of stay (1.5 vs 2.8 days,
p = 0.02), and overall hospitalization (4.9 vs 6.6 days, p = 0.01) without
an increase in mortality. Fewer strokes and deaths were observed in the OPC
AB group, but these trends failed to reach statistical significance.
Conclusions: In similar patient populations, OPCAB was associated with sign
ificantly fewer cerebral microemboli and improved clinical results without
an increase in mortality. We believe that these early results support OPCAB
as a viable and potentially safer alternative to traditional CABG.